Carella AM - Search Results

1

Imatinib-mesylate for all patients with hypereosinophilic syndrome?

Musto P, Perla G, Minervini MM, Carella AM, Coco FL, Catalano G. Musto P, et al. Among authors: carella am. Leuk Res. 2004 Jul;28(7):773-4. doi: 10.1016/j.leukres.2003.11.014. Leuk Res. 2004. PMID: 15158099 Free article. No abstract available.

2

Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patients.

Cascavilla N, Musto P, D'Arena G, Ladogana S, Melillo L, Carella AM, Perla G, Matera R, Carotenuto M. Cascavilla N, et al. Among authors: carella am. Leuk Lymphoma. 1996 May;21(5-6):437-42. doi: 10.3109/10428199609093441. Leuk Lymphoma. 1996. PMID: 9172808

3

Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.

Cascavilla N, Melillo L, D'Arena G, Greco MM, Carella AM, Sajeva MR, Perla G, Matera R, Minervini MM, Carotenuto M. Cascavilla N, et al. Among authors: carella am. Leuk Lymphoma. 2000 Mar;37(1-2):105-13. doi: 10.3109/10428190009057633. Leuk Lymphoma. 2000. PMID: 10721774

4

Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study.

Carella AM, Cascavilla N, Greco MM, Melillo L, Sajeva MR, Ladogana S, D'Arena G, Perla G, Carotenuto M. Carella AM, et al. Leuk Lymphoma. 2001 Jan;40(3-4):295-303. doi: 10.3109/10428190109057928. Leuk Lymphoma. 2001. PMID: 11426551 Clinical Trial.

5

Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term study.

Cascavilla N, Musto P, Melillo L, Bodenizza C, Dell'Olio M, Nobile M, Minervini MM, Perla G, D'Arena G, Carella AM. Cascavilla N, et al. Among authors: carella am. Hematol J. 2002;3(5):251-8. doi: 10.1038/sj.thj.6200186. Hematol J. 2002. PMID: 12391543

6

Usefulness of RA and RO isoforms of common leukocyte antigen (CD45) for early distinction between normal and abnormal promyelocytes.

D'Arena G, Cascavilla N, Nunziata G, Perla G, Matera R, Carella AM, Pistolese G. D'Arena G, et al. Among authors: carella am. Leuk Lymphoma. 2002 Sep;43(9):1823-5. doi: 10.1080/1042819021000006538. Leuk Lymphoma. 2002. PMID: 12685839

7

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, La Sala A, Perla G, Carella AM. Musto P, et al. Among authors: carella am. Br J Haematol. 2003 Jul;122(2):269-71. doi: 10.1046/j.1365-2141.2003.04435.x. Br J Haematol. 2003. PMID: 12846896 Free article. Clinical Trial.

8

Pamidronate for early-stage, untreated myeloma.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Carella AM. Musto P, et al. Among authors: carella am. J Clin Oncol. 2003 Aug 15;21(16):3177-8; author reply 3178. doi: 10.1200/JCO.2003.99.248. J Clin Oncol. 2003. PMID: 12915612 No abstract available.

9

Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Cascavilla N, Melillo L, Scalzulli PR, Dell'Olio M, La Sala A, Mantuano S, Nobile M, Carella AM. Musto P, et al. Among authors: carella am. Leuk Lymphoma. 2003 Sep;44(9):1545-8. doi: 10.3109/10428190309178778. Leuk Lymphoma. 2003. PMID: 14565658 Clinical Trial.

10

Inefficacy of imatinib-mesylate in sporadic, aggressive systemic mastocytosis.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Carella AM. Musto P, et al. Among authors: carella am. Leuk Res. 2004 Apr;28(4):421-2. doi: 10.1016/j.leukres.2003.09.001. Leuk Res. 2004. PMID: 15109544 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters